AgomAb Therapeutics NV American Depositary Shares (AGMB) — Financial Flexibility Index
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Financial Flexibility Index of -0.65x as of March 2026. Free cash flow of $-12.07 Million (operating CF $-12.44 Million minus capex $363.00K) represents -1% of total liabilities ($18.70 Million). Also explore AGMB net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AgomAb Therapeutics NV American Depositary Shares Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for AgomAb Therapeutics NV American Depositary Shares across 4 annual periods. Check AGMB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for AgomAb Therapeutics NV American Depositary Shares (2022–2025)
Year-by-year free cash flow to debt coverage for AgomAb Therapeutics NV American Depositary Shares. For the full company profile including market capitalisation, see AgomAb Therapeutics NV American Deposita (AGMB) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.27x | $-51.74 Million | $-51.74 Million | $22.80 Million | ▲ +10.2% |
| 2024 | -2.53x | $-46.15 Million | $-46.83 Million | $18.28 Million | ▼ -103.6% |
| 2023 | -1.24x | $-24.59 Million | $-24.59 Million | $19.82 Million | ▼ -127.3% |
| 2022 | -0.55x | $-18.97 Million | $-18.97 Million | $34.75 Million | — |